Maria Teresa Barrio-Lopez

Maria Teresa Barrio-Lopez

Auto-generated profile, based on publicly available information

Maria Teresa Barrio-Lopez

Electrophysiology Laboratory and Arrhythmia Unit HM CIEC Madrid (Centro Integral de Enfermedades Cardiovasculares), Hospital Universitario HM Montepríncipe, HM Hospitales Boadilla del Monte Madrid Spain

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2011 in BMC Public Health
Verified
Journal Article
Open access
PDF file
MBMaria Teresa Barrio-Lopez
Maria Teresa Barrio-Lopez
Maira Bes-RastrolloMaira Bes-Rastrollo
Maira Bes-Rastrollo
JBJuan Jose Beunza
Juan Jose Beunza
AFAlejandro Fernandez-Montero
Alejandro Fernandez-Montero
MGMartin Garcia-Lopez
Martin Garcia-Lopez
MMMiguel A. Martinez-Gonzalez
Miguel A. Martinez-Gonzalez
Background: The objective of this study was to evaluate the validity of self reported criteria of Metabolic Syndrome (MS) in the SUN (Seguimiento Universidad de Navarra) cohort using their medical records as the gold standard. Methods: We selected 336 participants and we obtained MS related data according to Adult Treatment Panel III (ATP III) and International Diabetes Federation (IDF). Then we compared information on the self reported diagnosis of MS and MS diagnosed in their medical records. We calculated the proportion of confirmed MS, the proportion of confirmed non-MS and the intraclass correlation coefficients for each component of the MS. Results: From those 336 selected participants, we obtained sufficient data in 172 participants to confirm or reject MS using ATP III criteria. The proportion of confirmed MS was 91.2% (95% CI: 80.7- 97.1) and the proportion of confirmed non-MS was 92.2% (95% CI: 85.7-96.4) using ATP III criteria. The proportion of confirmed MS using IDF criteria was 100% (95% CI: 87.2-100) and the proportion of confirmed non-MS was 97.1% (95% CI: 85.1-99.9). Kappa Index was 0.82 in the group diagnosed by ATP III criteria and 0.97 in the group diagnosed by IDF criteria. Intraclass correlation coefficients for the different component of MS were: 0.93 (IC 95%:0.91- 0.95) for BMI; 0.96 (IC 95%: 0.93-0.98) for waist circumference; 0.75 (IC 95%: 0.66-0.82) for fasting glucose; 0.50 (IC 95%:0.35-0.639) for HDL cholesterol; 0.78 (IC 95%: 0.70-0.84) for triglycerides; 0.49 (IC 95%:0.34-0.61) for systolic blood pressure and 0.55 (IC 95%: 0.41-0.65) for diastolic blood pressure. Conclusions: Self-reported MS based on self reported components of the SM in a Spanish cohort of university graduates was sufficiently valid as to be used in epidemiological studies.

10 November 2023 in European Journal of Preventive Cardiology
Verified
Journal Article
Closed access
PDF file
MBMaría Teresa Barrio-Lopez
María Teresa Barrio-Lopez
MRMiguel Ruiz-Canela
Miguel Ruiz-Canela
LGLeticia Goni
Leticia Goni
AVAlmudena Martinez Valiente
Almudena Martinez Valiente
SGSilvia Romero Garcia
Silvia Romero Garcia
JAJesus Almendral
Jesus Almendral
Aims: To analyse the relationship between Mediterranean diet (MedDiet) adherence and epicardial adipose tissue (EAT) in patients with atrial fibrillation (AF) and the association between EAT or MedDiet adherence at baseline with AF recurrence after ablation. Methods and results: We included 199 patients from the PREDIMAR trial (PREvención con DIeta Mediterránea de Arritmias Recurrentes), in a single centre in this substudy. All of them had a computed tomography with EAT measurement. Lifestyle and clinical characteristics were obtained at baseline. The traditional MedDiet pattern was defined according to the MedDiet Adherence Screener (MEDAS). Any documented AF > 30 s after ablation was considered a recurrence. Multivariable-adjusted linear and logistic regression models were run to assess the cross-sectional association of MedDiet with EAT, and of EAT with the AF type at baseline. Also, Cox regression models were used to prospectively assess the associations of MedDiet adherence and EAT with AF recurrences after ablation. Median EAT was 135 g (interquartile range: 112–177), and the mean MedDiet score was 7.75 ± 2 points. A higher MEDAS ≥ 7 that was associated with lower odds of an EAT ≥ 135 g [multivariable odds ratio (mOR) = 0.45; 95% CI = 0.22–0.91; P = 0.025] was significantly associated with persistent AF after adjusting for traditional risk factors (mOR: 2.22; 95% CI: 1.03–4.79; P = 0.042). No significant associations were observed between EAT ≥ 135 g and the risk of atrial tachyarrhythmia recurrences after ablation [multivariable-adjusted hazard ratio (mHR) = 1.18; 95% CI: 0.72–1.94; P = 0.512], or between MEDAS ≥ 7 and AF recurrence (mHR = 0.78; 95% CI: 0.47–1.31; P = 0.344). Conclusion: In patients with AF, higher adherence to MedDiet is associated with a significantly lower amount of EAT. Epicardial adipose tissue ≥ 135 g was significantly associated with persistent AF.

23 October 2024 in JACC: Clinical Electrophysiology
Verified
Journal Article
Closed access
MBMaría Teresa Barrio-Lopez
María Teresa Barrio-Lopez
CÁCarlos Álvarez-Ortega
Carlos Álvarez-Ortega
CMCarlos Minguito-Carazo
Carlos Minguito-Carazo
EFEduardo Franco
Eduardo Franco
PGPablo Elpidio García-Granja
Pablo Elpidio García-Granja
ÁMÁngel Moya-Mitjáns
Ángel Moya-Mitjáns

7 December 2020 in Journal of Medical Internet Research
Verified
Journal Article
Open access
LGLeticia Goni
Leticia Goni
VOVíctor de la O
Víctor de la O
MBM Teresa Barrio-López
M Teresa Barrio-López
PRPablo Ramos
Pablo Ramos
LTLuis Tercedor
Luis Tercedor
MRMiguel Ruiz-Canela
Miguel Ruiz-Canela
Background: The Prevention With Mediterranean Diet (PREDIMED) trial supported the effectiveness of a nutritional intervention conducted by a dietitian to prevent cardiovascular disease. However, the effect of a remote intervention to follow the Mediterranean diet has been less explored. Objective: This study aims to assess the effectiveness of a remotely provided Mediterranean diet–based nutritional intervention in obtaining favorable dietary changes in the context of a secondary prevention trial of atrial fibrillation (AF). Methods: The PREvention of recurrent arrhythmias with Mediterranean diet (PREDIMAR) study is a 2-year multicenter, randomized, controlled, single-blinded trial to assess the effect of the Mediterranean diet enriched with extra virgin olive oil (EVOO) on the prevention of atrial tachyarrhythmia recurrence after catheter ablation. Participants in sinus rhythm after ablation were randomly assigned to an intervention group (Mediterranean diet enriched with EVOO) or a control group (usual clinical care). The remote nutritional intervention included phone contacts (1 per 3 months) and web-based interventions with provision of dietary recommendations, and participants had access to a web page, a mobile app, and printed resources. The information is divided into 6 areas: Recommended foods, Menus, News and Online resources, Practical tips, Mediterranean diet classroom, and Your personal experience. At baseline and at 1-year and 2-year follow-up, the 14-item Mediterranean Diet Adherence Screener (MEDAS) questionnaire and a semiquantitative food frequency questionnaire were collected by a dietitian by phone. Results: A total of 720 subjects were randomized (365 to the intervention group, 355 to the control group). Up to September 2020, 560 subjects completed the first year (560/574, retention rate 95.6%) and 304 completed the second year (304/322, retention rate 94.4%) of the intervention. After 24 months of follow-up, increased adherence to the Mediterranean diet was observed in both groups, but the improvement was significantly higher in the intervention group than in the control group (net between-group difference: 1.8 points in the MEDAS questionnaire (95% CI 1.4-2.2; P<.001). Compared with the control group, the Mediterranean diet intervention group showed a significant increase in the consumption of fruits (P<.001), olive oil (P<.001), whole grain cereals (P=.002), pulses (P<.001), nuts (P<.001), white fish (P<.001), fatty fish (P<.001), and white meat (P=.007), and a significant reduction in refined cereals (P<.001), red and processed meat (P<.001), and sweets (P<.001) at 2 years of intervention. In terms of nutrients, the intervention group significantly increased their intake of omega-3 (P<.001) and fiber (P<.001), and they decreased their intake of carbohydrates (P=.02) and saturated fatty acids (P<.001) compared with the control group. Conclusions: The remote nutritional intervention using a website and phone calls seems to be effective in increasing adherence to the Mediterranean diet pattern among AF patients treated with catheter ablation. Trial Registration: ClinicalTrials.gov NCT03053843; https://www.clinicaltrials.gov/ct2/show/NCT03053843

25 May 2018 in Journal of Interventional Cardiac Electrophysiology
Verified
Journal Article
Closed access
PDF file
MBMaria Teresa Barrio-López
Maria Teresa Barrio-López
ECEduardo Castellanos
Eduardo Castellanos
MOMercedes Ortiz
Mercedes Ortiz
MAMartín Arceluz
Martín Arceluz
CLCarla Lázaro
Carla Lázaro
JAJesús Almendral
Jesús Almendral

10 February 2022 in Journal of Interventional Cardiac Electrophysiology
Verified
Journal Article
Closed access
PDF file
MBMaria Teresa Barrio-Lopez
Maria Teresa Barrio-Lopez
ECEduardo Castellanos
Eduardo Castellanos
ABAndres Betancur
Andres Betancur
BZBlanca Zorita
Blanca Zorita
JMJuan Medina
Juan Medina
JAJesús Almendral
Jesús Almendral